Clinical Trial Update: Phase 2 Study of OTL38 for Intra-operative Imaging of Folate Receptor-alpha Positive Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 study of OTL38 for intra-operative imaging in folate receptor-alpha positive ovarian cancer has completed with posted results in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• OTL38

Snippet

Sponsor: On Target Laboratories, LLC | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2022-06-21